Contra-indicated in patients with acute critical illiness; children with Prader-Willi syndrome who are severely obese or have severe respiratory impairment; active malignancy; active proliferative or severe non-proliferative diabetic retinopathy; or children with closed epiphyses.
- TRADE NAMES: Genotropin (Pfizer); Growject BC; Humatrope (Lilly); Norditropin (Novo Nordisk); Norditropin SimpleXx (Novo Nordisk); Nutropin (Genentech); NutropinAq (Ipsen); Omitrope; Saizen (Merck Serono); Scitropin A (Teva); Serostim (Merck Serono); Tev-Tropin (Teva); Zomacton (Ferring); Zorbtive (Merck Serono)
- INDICATIONS: Growth failure, growth hormone deficiency, short stature (in Turner's syndrome), muscle wasting (in HIV positive patients)
- SYNONYM: somatostatin
- CLASS: Growth hormone analog
- HALF-LIFE: 0.4 hours (intravenous); 3 hours (subcutaneous); 5 hours (intramuscular)
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Acarbose, Corticosteroids, Estradiol, Estrogens, Exenatide, Glucocorticoids, Insulin Aspart, Insulin Degludec, Insulin Detemir, Insulin Glargine, Insulin Glulisine, Metformin, Pioglitazone, Saxagliptin, Triamcinolone
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
